Short-term exposure evaluation of adult smokers switching from conventional to first-generation electrically heated cigarettes during controlled smoking.
This randomized, controlled study in 110 male and female adult smokers evaluated biomarkers of tobacco smoke exposure (carbon monoxide [CO], carboxyhemoglobin [CO-Hb], nicotine, urine mutagenicity) under controlled smoking conditions when adult smokers of 1 conventional cigarette brand (CC1) were switched to an electrically heated cigarette smoking system (EHCSS) or a low-tar conventional cigarette (CC2). Baseline exposure was determined while all subjects smoked CC1. Subjects then were stratified for gender and cigarette consumption and randomized to 1 of 5 groups-EHCSS1, EHCSS2, CC1, CC2, or no smoking-and monitored for 8 days. Compared to baseline, biomarkers of exposure on day 8 decreased 53% to 93% (P < .0001) for EHCSS groups and 18% to 39% (P < .02) for CC2. Environmental tobacco smoke arising from the smoking activities of the different study groups was measured in the air of a separate smoking room over 1-hour periods. Concentrations of respirable suspended particulates in both EHCSS groups were about 90% lower than in the CC1 and CC2 groups, similar to the 95% reduction in the no-smoking group. CO was undetectable in the EHCSS and no-smoking groups. Results from this short-term clinical study indicate that switching from a conventional cigarette to a first-generation EHCSS reduces the generation of environmental tobacco smoke and can reduce the exposure to the measured, potentially harmful constituents in tobacco smoke if smokers do not compensate by numbers of cigarettes. The study design was found to be suitable for the evaluation of the exposure of adult smokers to the measured smoke constituents and to allow the differentiation of different cigarette designs.
Roethig
Hans J
HJ
Philip Morris USA, Clinical Evaluation, 615 Maury Street, Richmond, VA 23224-4121, USA.
Kinser
Robin D
RD
Lau
Raymond W
RW
Walk
Ruediger-A
RA
Wang
Nancy
N
D000328:Adult; D002248:Carbon Monoxide / Q000032:analysis; D002263:Carboxyhemoglobin / Q000032:analysis; D004560:Electricity; D005260:Female; D006261:Headache / Q000139:chemically induced; D006361:Heating / Q000295:instrumentation*; D006801:Humans; D008297:Male; D009152:Mutagenicity Tests; D009153:Mutagens / Q000009:adverse effects / Q000737:chemistry / Q000378:metabolism; D009538:Nicotine / Q000652:urine; D012907:Smoking / Q000009:adverse effects* / Q000453:epidemiology; D013638:Tars / Q000032:analysis; D013696:Temperature; D013997:Time Factors; D019460:Tobacco Industry / Q000295:instrumentation / Q000379:methods; D014028:Tobacco Smoke Pollution / Q000009:adverse effects; D014026:Nicotiana
D009153:Mutagens; D013638:Tars; D014028:Tobacco Smoke Pollution; C024746:tobacco tar; D009538:Nicotine; D002248:Carbon Monoxide; D002263:Carboxyhemoglobin